Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Bulletin Du Cancer
|
September 12, 2024
[Real-life evaluation of the care pathway of patients eligible for axicabtagene ciloleucel treatment: Analysis of a multicenter retrospective cohort (IMPA-CT study)]
Guillaume Cartron, Catherine Thieblemont, Isabelle Borget, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 31, 2017
Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors
Livia Lamartina, Isabelle Borget, Haitham Mirghani, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 3, 2012
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels
Sophie Leboulleux, Intidhar El Bez, Isabelle Borget, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 1, 2016
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer
Marie Terroir, Isabelle Borget, François Bidault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer
Emma Pailler, Julien Adam, Amélie Barthélémy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies
Stephen Palmer, Isabelle Borget, Tim Friede, et al.
Hormones & Cancer
|
July 28, 2017
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients
Julien Hadoux, Marie Terroir, Sophie Leboulleux, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2017
Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs)
Eleonor Rivin Del Campo, Sofia Rivera, María Martínez-Paredes, et al.
Therapie
|
January 4, 2026
How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Therapie
|
January 21, 2026
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Bulletin Du Cancer
|
September 12, 2024
[Real-life evaluation of the care pathway of patients eligible for axicabtagene ciloleucel treatment: Analysis of a multicenter retrospective cohort (IMPA-CT study)]
Guillaume Cartron, Catherine Thieblemont, Isabelle Borget, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 31, 2017
Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors
Livia Lamartina, Isabelle Borget, Haitham Mirghani, et al.
Thyroid : Official Journal of the American Thyroid Association
|
August 3, 2012
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels
Sophie Leboulleux, Intidhar El Bez, Isabelle Borget, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 1, 2016
The intensity of 18FDG uptake does not predict tumor growth in patients with metastatic differentiated thyroid cancer
Marie Terroir, Isabelle Borget, François Bidault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 15, 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer
Emma Pailler, Julien Adam, Amélie Barthélémy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 15, 2022
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies
Stephen Palmer, Isabelle Borget, Tim Friede, et al.
Hormones & Cancer
|
July 28, 2017
Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients
Julien Hadoux, Marie Terroir, Sophie Leboulleux, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 24, 2017
Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs)
Eleonor Rivin Del Campo, Sofia Rivera, María Martínez-Paredes, et al.
Therapie
|
January 4, 2026
How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Therapie
|
January 21, 2026
Clémentine Body, Frédéric Chassagnol, Driss Berdaï, et al.
Page
of 14